Lv5
1060 积分 2021-04-07 加入
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
3天前
已完结
Factors Associated With Dupilumab Response in Atopic Dermatitis: A Systematic Review and Meta-Analysis
8天前
已完结
High-resolution mapping of allergenic pollen risk across China using ensemble machine learning
22天前
已完结
Pollen exposure and mild allergy: A multi-city study in China
22天前
已完结
Late Breaking Abstract - Early improvement in asthma small airway dysfunction after one dose of SAR443765, a novel bispecific anti-thymic stromal lymphopoietin/anti-IL-13 nanobody molecule
26天前
已关闭
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial
1个月前
已完结
Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta‐Analysis
2个月前
已完结
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
2个月前
已完结
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
3个月前
已完结
皖公网安备34019202002308
